Follow

Submissions from 2021

Identification of HU Window for Accurate Contouring of Metal Implants, Jen Yu, Andrew Wroe, and Alonso Gutierrez

Submissions from 2020

PDF

Multi-Institutional Experience Of Proton Beam Radiotherapy For Patients With Craniopharyngiomas, Haley Appel, Muni Rubens, Matthew Hall, Minesh Mehta, and Rupesh Kotecha

PDF

Multi-Institutional Experience of Proton Beam Radiotherapy for Pediatric Ependymomas, Haley Appel, Muni Rubens, Matthew Hall, Minesh Mehta, and Rupesh Kotecha

Tissue Oxygenation Changes in Response to Radiation Therapy in Breast Cancer Subjects Using Near-Infrared Optical Imaging, Corina Beiner, Maria-Amelia Rodrigues, and Michael Chuong

PDF

Psychosocial Support for Pediatric Patients at Proton Therapy Institutions, Nicole Boik and Matthew Hall

PDF

Beyond an Updated Graded Prognostic Assessment (Breast GPA): A Prognostic Index and Trends in Treatment and Survival in Breast Cancer Brain Metastases From 1985 to Today, John Bryant, Michael Chuong, and Minesh Mehta

PDF

Estrogen/progesterone receptor and HER2 discordance between primary tumor and brain metastases in breast cancer and its effect on treatment and survival, John Bryant, Michael Chuong, and Minesh Mehta

PDF

Survival in Patients With Brain Metastases: Summary Report on the Updated Diagnosis-Specific Graded Prognostic Assessment and Definition of the Eligibility Quotient, John Bryant, Michael Chuong, and Minesh Mehta

PDF

Favorable Initial Outcomes of Abdominopelvic Reirradiation Using Dose-Escalated Magnetic Resonance Image-Guided Radiation Therapy, John Bryant, Kathryn Mittauer, Rupesh Kotecha, Jessika Contreras, Diane Alvarez, Noah Kalman, Matthew Hall, Gustavo Luciani, Tino Romaguera, Vivek Mishra, Minesh Mehta, Alonso Gutierrez, and Michael Chuong

PDF

Immunotherapy and radiation therapy for gastrointestinal malignancies: hope or hype?, Michael Chuong

PDF

Magnetic Resonance Guided Radiotherapy for Rectal Cancer: Expanding Opportunities for Non-Operative Management, Michael Chuong

PDF

Minimal acute toxicity from proton beam therapy for major salivary gland cancer, Michael Chuong

PDF

Proton beam therapy for liver cancers, Michael Chuong

PDF

Single-Fraction Stereotactic Body Radiation Therapy: A Paradigm During the Coronavirus Disease 2019 (COVID-19) Pandemic and Beyond?, Michael Chuong

PDF

The Utility of PET/Computed Tomography for Radiation Oncology Planning, Surveillance, and Prognosis Prediction of Gastrointestinal Tumors, Michael Chuong

PDF

Case report of ablative magnetic resonance-guided stereotactic body radiation therapy for oligometastatic mesenteric lymph nodes from bladder cancer, Michael Chuong, Diane Alvarez, Tino Romaguera, Kathryn Mittauer, Sonia Adamson, Alonso Gutierrez, Gustavo Luciani, Hayden Guerrero Olmo, and Antonio Ucar

PDF

Ablative Dose Prescribed to Oligometastases Near Gastrointestinal Luminal Structures is Well Tolerated Using Stereotactic Magnetic Resonance Image-Guided Adaptive Radiation Therapy (SMART), Michael Chuong, Jessika Contreras, Rupesh Kotecha, Noah Kalman, Tino Romaguera, Alonso Gutierrez, Kathryn Mittauer, Diane Alvarez, Gustavo Luciani, and Matthew Hall

PDF

Median 50 Gy in 5 Consecutive Fractions Delivered with Stereotactic Magnetic Resonance Image-guided Radiation Therapy for Inoperable Pancreas Cancer, Michael Chuong, Rupesh Kotecha, Matthew Hall, Jessika Contreras, Kathryn Mittauer, Diane Alvarez, Tino Romaguera, Gustavo Luciani, Vivek Mishra, and Alonso Gutierrez

PDF

Radiotherapy and Late Effects, Matthew Hall

PDF

Residual setup errors in cranial stereotactic radiosurgery without six degree of freedom robotic couch: Frameless versus rigid immobilization systems, Matthew Hall

PDF

Pediatric bithalamic gliomas have a distinct epigenetic signature and frequent EGFR exon 20 insertions resulting in potential sensitivity to targeted kinase inhibition, Matthew Hall and Minesh Mehta

PDF

Simulation of an HDR "Boost" with Stereotactic Proton versus Photon Therapy in Prostate Cancer: A Dosimetric Feasibility Study, Adeel Kaiser

PDF

Analyzing the role of adjuvant or salvage radiotherapy for spinal myxopapillary ependymomas, Rupesh Kotecha

PDF

Brain metastases from non-small cell lung cancer with EGFR or ALK mutations: A systematic review and meta-analysis of multidisciplinary approaches, Rupesh Kotecha

CTIM-22. PHASE 1 TRIAL OF OSIMERTINIB WITH STEREOTACTIC RADIOSURGERY (SRS) IN PATIENTS WITH BRAIN METASTASES FROM EGFR POSITIVE NON-SMALL-CELL LUNG CANCER (NSCLC), Rupesh Kotecha

PDF

Current approaches to the management of brain metastases, Rupesh Kotecha

PDF

Management of recurrent or progressive spinal metastases: reirradiation techniques and surgical principles, Rupesh Kotecha

PDF

Multi-institutional validation of brain metastasis velocity, a recently defined predictor of outcomes following stereotactic radiosurgery, Rupesh Kotecha

PDF

Response to letter regarding "Stereotactic radiosurgery for nonfunctioning pituitary adenomas: meta-analysis and International Society of Stereotactic Radiosurgery (ISRS) practice opinion", Rupesh Kotecha

PDF

Impact of Radiotherapy Dosimetric Parameters on Neurocognitive Function in Brain Tumor Patients, Rupesh Kotecha and Matthew Hall

PDF

Extreme Hypofractionation for Newly Diagnosed Glioblastoma: Rationale, Dose, Techniques, and Outcomes, Rupesh Kotecha and Minesh Mehta

PDF

Stereotactic Radiosurgery for Non-Functioning Pituitary Adenomas: Meta-Analysis and International Society of Stereotactic Radiosurgery (ISRS) Practice Opinion, Rupesh Kotecha and Muni Rubens

PDF

Radiation therapy alone versus radiation therapy plus radiofrequency ablation/vertebral augmentation for spine metastasis: study protocol for a randomized controlled trial, Rupesh Kotecha, Brian Schiro, Justin Sporrer, Muni Rubens, Haley Appel, Kathleen Calienes, Belinda Boulanger, Marietsy Pujol, Deborah Suarez, Ashley Pena, Alex Kudryashev, and Minesh Mehta

Pulsed-reduced dose rate (PRDR) radiotherapy for recurrent primary central nervous system malignancies: dosimetric and clinical results, Tugce Kutuk, Alexander Mohler, Nicole McAllister, Matthew Hall, Martin Tom, Haley Appel, Ranjini Tolakanahalli, Alonso Gutierrez, Yazmin Odia, Manmeet Ahluwalia, Minesh Mehta, and Rupesh Kotecha

PDF

30. RADIOSURGERY FOLLOWED BY TUMOR TREATING FIELDS FOR BRAIN METASTASES (1–10) FROM NSCLC IN THE PHASE 3 METIS TRIAL, Minesh Mehta

PDF

Comprehensive Genomic Analysis in NRG Oncology/RTOG 9802: A Phase III Trial of Radiation Versus Radiation Plus Procarbazine, Lomustine (CCNU), and Vincristine in High-Risk Low-Grade Glioma, Minesh Mehta

PDF

Effectiveness of Radiofrequency Ablation in the Treatment of Painful Osseous Metastases: A Correlation Meta-Analysis with Machine Learning Cluster Identification, Minesh Mehta

PDF

Glioblastoma in Adults: A Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) Consensus Review on Current Management and Future Directions, Minesh Mehta

PDF

High-risk meningioma: Initial outcomes from NRG Oncology/RTOG 0539, Minesh Mehta

PDF

Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001, Minesh Mehta

Investigating Low-Dose Thoracic Radiation as a Treatment for COVID-19 Patients to Prevent Respiratory Failure, Minesh Mehta

PDF

Low-Dose Radiation Therapy (LDRT) for COVID-19: Benefits or Risks?, Minesh Mehta

PDF

NRG/RTOG 1122: A phase 2, double-blinded, placebo-controlled study of bevacizumab with and without trebananib in patients with recurrent glioblastoma or gliosarcoma, Minesh Mehta

PDF

Optimizing eligibility criteria and clinical trial conduct to enhance clinical trial participation for primary brain tumor patients, Minesh Mehta

PDF

Phase 2 Study of a Temozolomide-Based Chemoradiation Therapy Regimen for High-Risk, Low-Grade Gliomas: Long-Term Results of Radiation Therapy Oncology Group 0424, Minesh Mehta

PDF

Phase I/II study of sorafenib in combination with erlotinib for recurrent glioblastoma as part of a 3-arm sequential accrual clinical trial: NABTC 05-02, Minesh Mehta

PDF

Phase II Study of a Temozolomide-Based Chemo-radiotherapy Regimen for High Risk Low-Grade Gliomas: Long-term Results of Radiation Therapy Oncology Group (RTOG) 0424, Minesh Mehta

PDF

Putative Abscopal Effect in Three Patients Treated by Combined Radiotherapy and Modulated Electrohyperthermia, Minesh Mehta

PDF

Radiotherapy Innovations to Optimize Brain Metastases Control, Minesh Mehta

CTIM-15. PRELIMINARY RESULTS OF A PHASE II STUDY OF NIVOLUMAB WITH HYPOFRACTIONATED RE-RADIATION AND BEVACIZUMAB FOR RECURRENT MGMT METHYLATED GLIOBLASTOMA, Minesh Mehta, Rupesh Kotecha, and Yazmin Odia

CTNI-17. CLINICAL EFFICACY AND PREDICTIVE BIOMARKERS OF ONC201 IN H3 K27M-MUTANT DIFFUSE MIDLINE GLIOMA, Minesh Mehta, Yazmin Odia, Matthew Hall, and Doured Daghistani

PDF

HGG-18. CLINICAL EFFICACY OF ONC201 IN THALAMIC H3 K27M-MUTANT GLIOMA, Minesh Mehta, Yazmin Odia, Matthew Hall, and Doured Daghistani

PDF

A Novel Pre-plan Technique for On-table Adaptation of Pancreatic Stereotactic MR-guided Online Adaptive Radiotherapy, Kathryn Mittauer, Michael Chuong, Jessika Contreras, Diane Alvarez, Tino Romaguera, Rupesh Kotecha, Matthew Hall, Minesh Mehta, and Alonso Gutierrez

PDF

DIPG-52. PHASE I CLINICAL TRIAL OF ONC201 IN PEDIATRIC H3 K27M-MUTANT GLIOMA OR NEWLY DIAGNOSED DIPG, Yazmin Odia, Matthew Hall, and Doured Daghistani

ONC201 in previously irradiated pediatric H3 K27M-mutant glioma or newly diagnosed DIPG, Yazmin Odia, Matthew Hall, and Doured Daghistani

PDF

Biological activity of weekly ONC201 in adult recurrent glioblastoma patients, Yazmin Odia and Minesh Mehta

Clinical experience of ONC201 in patients with recurrent H3 K27M-mutant spinal cord glioma, Yazmin Odia and Minesh Mehta

PDF

Early imaging marker of progressing glioblastoma: a window of opportunity, Yazmin Odia and Minesh Mehta

Single-agent ONC201 in recurrent H3 K27M-mutant diffuse midline glioma, Yazmin Odia and Minesh Mehta

PDF

Design of a focused collimator for proton therapy spot scanning using Monte Carlo methods, Suresh Rana

PDF

Parametrization of in-air spot size as a function of energy and air gap for the ProteusPLUS pencil beam scanning proton therapy system, Suresh Rana

PDF

Investigating beam matching for multi-room pencil beam scanning proton therapy, Suresh Rana and Jaafar Bennouna

PDF

Evaluation of spot size using volumetric repainting technique on a ProteusPLUS PBS Proton Therapy System, Suresh Rana, Jaafar Bennouna, and Alonso Gutierrez

PDF

Impact of magnetic field regulation in conjunction with the volumetric repainting technique on the spot positions and beam range in pencil beam scanning proton therapy, Suresh Rana, Jaafar Bennouna, and Alonso Gutierrez

Quantification of radiation and imaging isocenter coincidence of a multi-room PBS proton therapy system, Suresh Rana, Jaafar Bennouna, and Alonso Gutierrez

RADT-31. PATTERNS OF CARE IN THE USE OF ADJUVANT RADIOTHERAPY AND CHEMOTHERAPY IN LOW GRADE GLIOMA PATIENTS IN THE UNITED STATES FROM 2010-2016, Warren Rehrer, Yazmin Odia, Muni Rubens, Noah Kalman, Michael Chuong, Rupesh Kotecha, Minesh Mehta, and Matthew Hall

PDF

The Use of Adjuvant Radiotherapy and Chemotherapy in Low Grade Glioma Patients in the United States from 2010-2016, Warren Rehrer, Muni Rubens, Katherine Von Werne, Yazmin Odia, Michael Chuong, Rupesh Kotecha, Minesh Mehta, and Matthew Hall

PDF

Principles of Radiation Therapy in Breast Cancer, Maria-Amelia Rodrigues

PDF

Recent Health Care Expenditure Trends Among Adult Cancer Survivors in United States, 2009-2016, Muni Rubens, Anshul Saxena, Sankalp Das, Chintan Bhatt, Emir Veledar, Peter McGranaghan, Ana Viamonte Ros, Yuliya Linhares, Yazmin Odia, Michael Chuong, Rupesh Kotecha, and Minesh Mehta

PDF

Survival Impact Of Postoperative Radiotherapy Timing In Pediatric And Young Adult Ependymoma, Sunny Shah, Kevin Gates, Chase Mallory, Muni Rubens, Haley Appel, Noah Kalman, Rupesh Kotecha, Minesh Mehta, and Matthew Hall

PDF

Safety of Proton Therapy for Patients With Primary Central Nervous System Germinoma and Non-Germinomatous Germ Cell Tumors: Report from a Multi-Institutional Database Analysis, Katherine Von Werne, Melanie Naranjo, Haley Appel, Warren Rehrer, Muni Rubens, Michael Chuong, Minesh Mehta, Rupesh Kotecha, and Matthew Hall

Submissions from 2019

PDF

Prediction of Anal Cancer Recurrence After Chemoradiotherapy Using Quantitative Image Features Extracted From Serial (18)F-FDG PET/CT, Michael Chuong

PDF

Consensus Report From the Miami Liver Proton Therapy Conference, Michael Chuong and Alonso Gutierrez

PDF

Estimating survival in patients with gastrointestinal cancers and brain metastases: An update of the graded prognostic assessment for gastrointestinal cancers (GI-GPA), Michael Chuong and Minesh Mehta

PDF

Survival and prognostic factors in patients with gastrointestinal cancers and brain metastases: have we made progress?, Michael Chuong and Minesh Mehta

PDF

EBV-positive primary CNS lymphoma restricted to the conus medullaris in an immunocompetent host, Matthew Hall, Lyle Feinstein, Sergio Gonzalez-Arias, and Yazmin Odia

First clinical experience with DRD2/3 antagonist ONC201 in H3 K27M-mutant pediatric diffuse intrinsic pontine glioma: a case report, Matthew Hall, Yazmin Odia, Doured Daghistani, and Minesh Mehta

PDF

Pediatric and adult H3 K27M-mutant diffuse midline glioma treated with the selective DRD2 antagonist ONC201, Matthew Hall, Yazmin Odia, and Minesh Mehta

CMET-06. AN ANALYSIS OF RESPONSE ENDPOINTS FOR BRAIN METASTASIS PATIENTS TREATED WITH STEREOTACTIC RADIOSURGERY AND PD(L)-1 INHIBITORS, Rupesh Kotecha

PDF

Stereotactic radiosurgery with concurrent HER2-directed therapy is associated with improved objective response for breast cancer brain metastasis, Rupesh Kotecha

PDF

Stereotactic radiosurgery with concurrent lapatinib is associated with improved local control for HER2-positive breast cancer brain metastases, Rupesh Kotecha

PDF

Ten-year outcomes of moderately hypofractionated (70 Gy in 28 fractions) intensity modulated radiotherapy for localized prostate cancer, Rupesh Kotecha

PDF

The Impact of Sequencing PD-1/PD-L1 Inhibitors and Stereotactic Radiosurgery for Patients with Brain Metastasis, Rupesh Kotecha

PDF

The Complexity of Managing Large Brain Metastasis, Rupesh Kotecha and Minesh Mehta

PDF

Updates in the management of intradural spinal cord tumors: a radiation oncology focus, Rupesh Kotecha and Minesh Mehta

PDF

Barriers to Accrual and Enrollment in Brain Tumor Trials, Minesh Mehta

PDF

Comparison of Epidemiology and Outcomes in Neuro-Oncology Between the East and the West: Challenges and Opportunities, Minesh Mehta

PDF

Defining an Intermediate-risk Group for Low-grade Glioma: A National Cancer Database Analysis, Minesh Mehta

PDF

Epidermal growth factor receptor (EGFR) amplification rates observed in screening patients for randomized trials in glioblastoma, Minesh Mehta

PDF

Influence of Residual Disease Following Surgical Resection in Newly Diagnosed Glioblastoma on Clinical, Neurocognitive, and Patient Reported Outcomes, Minesh Mehta

PDF

Letter: When Less is More: Dexamethasone Dosing for Brain Tumors, Minesh Mehta

PDF

Low-Grade Glioma Radiotherapy Treatment and Trials, Minesh Mehta

PDF

Management of patients with brain metastases from non-small cell lung cancer and adverse prognostic features: multi-national radiation treatment recommendations are heterogeneous, Minesh Mehta

PDF

MGMT promoter methylation status testing to guide therapy for glioblastoma: refining the approach based on emerging evidence and current challenges, Minesh Mehta

PDF

NRG brain tumor specialists consensus guidelines for glioblastoma contouring, Minesh Mehta

PDF

Preoperative Vs Postoperative Radiosurgery For Resected Brain Metastases: A Review, Minesh Mehta

PDF

Pretreatment Volume of MRI-Determined White Matter Injury Predicts Neurocognitive Decline After Hippocampal Avoidant Whole-Brain Radiation Therapy for Brain Metastases: Secondary Analysis of NRG Oncology Radiation Therapy Oncology Group 0933, Minesh Mehta

PDF

The association between BMI and BSA–temozolomide-induced myelosuppression toxicities: a correlative analysis of NRG oncology RTOG 0525, Minesh Mehta

PDF

Feasibility study of utilizing XRV-124 scintillation detector for quality assurance of spot profile in pencil beam scanning proton therapy, Suresh Rana

PDF

Measurements of in-air spot size of pencil proton beam for various air gaps in conjunction with a range shifter on a ProteusPLUS PBS dedicated machine and comparison to the proton dose calculation algorithms, Suresh Rana